เกี่ยวกับ HCP Safety App
Quick reference to immune-mediated adverse reactions associated with OPDIVO®
Please see links to U.S. Full Prescribing Information for OPDIVO at http://packageinserts.bms.com/pi/pi_opdivo.pdf and YERVOY® (ipilimumab) at http://packageinserts.bms.com/pi/pi_yervoy.pdf including BOXED WARNING regarding immune-mediated adverse reactions, for YEROY.
HCP Adverse Reactions Guide
Your quick reference to the immune-mediated adverse reactions associated with OPDIVO® treatment. The Immune-Mediated Adverse Reactions (IMARs) Guide App for OPDIVO treatment can be viewed on your phone or tablet providing on-the-go information at your fingertips.
- Learn more about clarifying and addressing OPDIVO associated IMARs
- Find detailed monitoring guidance and symptomatology in quick reference format
- Includes organ-specific IMAR algorithms
Please visit www.OPDIVO.com or call 1-855-OPDIVO-1 (1-855-673-4861) for more information.
From Bristol-Myers Squibb
For U.S. Healthcare Professionals
What's new in the latest 1.2.0
ข้อมูล HCP Safety App APK
HCP Safety App รุ่นเก่า
HCP Safety App 1.2.0
HCP Safety App 1.1.0

การดาวน์โหลดที่รวดเร็วและปลอดภัยเป็นพิเศษผ่านแอป APKPure
คลิกเพียงครั้งเดียวเพื่อติดตั้งไฟล์ XAPK/APK บน Android!